Shanghai Fosun Pharmaceutical (Group) Balance Sheet Health
Financial Health criteria checks 4/6
Shanghai Fosun Pharmaceutical (Group) has a total shareholder equity of CN¥59.2B and total debt of CN¥32.6B, which brings its debt-to-equity ratio to 55%. Its total assets and total liabilities are CN¥115.3B and CN¥56.1B respectively. Shanghai Fosun Pharmaceutical (Group)'s EBIT is CN¥2.4B making its interest coverage ratio -1.4. It has cash and short-term investments of CN¥15.6B.
Key information
55.0%
Debt to equity ratio
CN¥32.56b
Debt
| Interest coverage ratio | -1.4x |
| Cash | CN¥15.63b |
| Equity | CN¥59.19b |
| Total liabilities | CN¥56.07b |
| Total assets | CN¥115.26b |
Recent financial health updates
Here's Why Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Has A Meaningful Debt Burden
Jul 28
Is Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) A Risky Investment?
Mar 18Recent updates
Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Is Paying Out Less In Dividends Than Last Year
Aug 03Here's Why Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Has A Meaningful Debt Burden
Jul 28Market Still Lacking Some Conviction On Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196)
May 23Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Just Missed EPS By 15%: Here's What Analysts Think Will Happen Next
May 01We Think You Can Look Beyond Shanghai Fosun Pharmaceutical (Group)'s (SHSE:600196) Lackluster Earnings
Apr 02Is Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) A Risky Investment?
Mar 18Are Investors Undervaluing Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196) By 48%?
Feb 26Financial Position Analysis
Short Term Liabilities: 600196's short term assets (CN¥34.5B) do not cover its short term liabilities (CN¥37.5B).
Long Term Liabilities: 600196's short term assets (CN¥34.5B) exceed its long term liabilities (CN¥18.6B).
Debt to Equity History and Analysis
Debt Level: 600196's net debt to equity ratio (28.6%) is considered satisfactory.
Reducing Debt: 600196's debt to equity ratio has reduced from 68.1% to 55% over the past 5 years.
Debt Coverage: 600196's debt is not well covered by operating cash flow (12.1%).
Interest Coverage: 600196 earns more interest than it pays, so coverage of interest payments is not a concern.